Jonathan Shackman is currently a Principal Scientist in the Chemical & Synthetic Development department at Bristol-Myers Squibb (BMS) supporting drug development for both small molecule and biologics from pre-clinical through marketed products. He graduated with two baccalaureate degrees (Biochemistry and a double major in Chemistry / Molecular & Cellular Biology) from the University of Arizona and was awarded the Outstanding Chemistry Senior award in 2000. His Analytical Chemistry Ph.D. program began at the University of Florida under Prof. Robert Kennedy and was part of the group that transitioned the lab to the University of Michigan. Research with Dr. Kennedy primarily focused on the development and applications of microfluidic-based immunoassays, with a moonlighting job of writing most of the group’s LabVIEW programs. After graduation in 2005, he held a National Research Council position at the National Institute of Standards and Technology (NIST) developing new electrophoretic separation techniques with a range of applications from forensics to astrobiology. After NIST, Jonathan served as an Assistant Professor in Analytical Chemistry at Temple University, teaching and supervising a graduate research group studying novel separations, microfluidics, and applications to biological systems. In 2010 he joined BMS, where he has received 9 awards, including the 2017 BMS Chemistry Leadership Award.
